To include your compound in the COVID-19 Resource Center, submit it here.

Biocad's rituximab biosimilar approved in Russia

Biocad (St. Petersburg, Russia) said the Russian

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE